Blansko, Czechia

Katerina Jelinkova

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Synthon B.v.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katerina Jelinkova. Retrieved from https://idiyas.com/inventor/katerina-jelinkova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katerina Jelinkova - Innovator in Pharmaceutical Chemistry

Introduction

Katerina Jelinkova is a notable inventor based in Blansko, Czech Republic. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her inventive work on crystalline forms of lenvatinib besylate.

Latest Patents

Katerina holds one patent, titled "Crystalline forms and processes of lenvatinib besylate." This innovative patent relates to lenvatinib besylate, detailing not only its crystalline forms but also the processes for producing them. Furthermore, it encompasses a pharmaceutical composition that includes a therapeutically effective dose of lenvatinib besylate, highlighting its relevance in medical applications.

Career Highlights

Currently, Katerina is associated with Synthon B.V., where she applies her expertise in pharmaceutical development. Her work not only enhances the understanding of lenvatinib besylate but also contributes to advancements in therapies for serious health conditions.

Collaborations

Throughout her career, Katerina has collaborated with esteemed colleagues, including Luis Nogueiras Nieto and Lisardo Alvarez Fernandez. This teamwork has been instrumental in the exploration and development of novel pharmaceutical solutions.

Conclusion

Katerina Jelinkova's contributions to the field of pharmaceutical chemistry exemplify her dedication to innovation and improvement in therapeutic treatments. Her patent on lenvatinib besylate showcases the impact that inventors like her have on the medical industry, assisting in the development of effective pharmaceutical compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…